Test Bank for Ruppel’s Manual of Pulmonary Function Testing
12th Edition, By Mottram
Chapter 1 - 13 Updated
,Chapter 1: Indications for Pulmonary Function Testing Test Bank
MULTIPLE CHOICE
1. Who first popularized spirometry for the evaluation of pulmonary function?
a. August and Marie Krogh
b. Alvan Barach
c. John Severinghaus
d. John Hutchinson
ANS: D
Hutchinson popularized the concept of using VC to assess lung function, and the names he
gave to several other lung compartments are still used today.
DIF: 1 REF: p. 2 OBJ: None MSC: NBRC: None
2. Which of the following are indications for performing spirometry?
1. Assess the risk of lung resection.
2. Determine the response to bronchodilator therapy.
3. Assess the severity of restrictive lung disease.
4. Quantify the extent of COPD.
a. 1 and 4
b. 2 and 3
c. 1 , 2, and 4
d. 2 , 3, and 4
ANS: C
Spirometry cannot assess severity of restriction; for that you need to measure lung volumes (
see Box 1-2, Chapter 1).
DIF: 1 REF: p. 7 OBJ: EL-2 MSC: NBRC: None
3. The main indication for the measurement of lung volumes is to do which of the following?
a. Diagnose or assess the severity of restriction.
b. Evaluate the severity of pulmonary hypertension.
c. Determine the level of cardiopulmonary fitness.
d. Assess the risk of abdominal surgical procedures.
ANS: A
The most common reason for measuring lung volumes is to identify restrictive lung
disease. DIF: 1 REF: p. 35 OBJ: EL-2 MSC: NBRC: None
4. DLCO measurements may be indicated to evaluate pulmonary involvement in which of
the following systemic diseases?
, a. Asthma
b. Sarcoidosis
c. Exertional hypoxemia
d. Guillain-Barré syndrome
ANS: B
Sarcoidosis is the only systemic disease listed that affects gas exchange.
DIF: 1 REF: p. 9 | p. 19 | p. 21 | p. 35 OBJ: EL-2 MSC: NBRC: None
5. Blood gas analysis is used with patients with COPD to do which of the
following?
a. Monitor airway responsiveness.
b. Determine level of cardiopulmonary fitness.
c. Detect pulmonary hypertension.
d. Assess need for supplementary O2.
ANS: D
Blood gas analysis is most commonly used to determine the need for supplemental oxygen
and to manage patients who require ventilatory support.
DIF: 2 REF: p. 15 OBJ: EL-1
MSC: NBRC: CPFT 2A-2
6. Which of the following cause emphysema?
1. 1- Antitrypsin deficiency
2. Exposure to environmental pollutants
3. Radiation therapy
4. Cigarette smoking
a. 1 and 2
b. 3 and 4
c. 1 , 2, and 4
d. 2 , 3, and 4
ANS: C
Emphysema is caused primarily by cigarette smoking. Some emphysema is caused by the
absence of a protective enzyme. Chronic exposure to environmental pollutants can also
contribute to the development of emphysema.
DIF: 1 REF: p. 11 OBJ: EL-3 | AL-2 MSC: NBRC: None
7. An adult patient complains of chest tightness and cough whenever he jogs in cold
weather. These symptoms are consistent with which of the following?
a. Cystic fibrosis
b. Asthma
c. Pulmonary hypertension
d. Idiopathic pulmonary fibrosis
|
, ANS: aB
Agents aor aevents athat acause aan aasthmatic aepisode aare acalled atriggers a(see aBox a1-7,
aChapter a1). aAntigens asuch aas aanimal adander, apollens, aand adusts aare athe amost
acommon atriggers. aOther acommon atriggers ainclude aexposure ato aair apollutants aand
aexercise ain acold aor adry aair.
DIF: 2 REF: p. a16 OBJ: EL-3 MSC: aNBRC: aNone
8. Which aof athe afollowing astatements aconcerning atumors ain athe aupper aairway ais atrue?
a. There amay abe avariable aor afixed aobstruction.
b. Fixed aobstruction awill abe apresent.
c. Variable aobstruction awill abe apresent.
d. Small aairway aobstruction awill aresult.
ANS: aA
Tumors ainvolving athe aupper aairway amay acause avariable aor afixed aobstruction.
DIF: 2 REF: p. a19 OBJ: EL-2
aMSC: aNBRC: aCPFT a3C-3
9. Sarcoidosis ais aa asystemic adisorder athat ausually acauses awhich aof athe afollowing?
a. A arestrictive aventilatory adefect
b. An aobstructive aventilatory adefect
c. Hyperreactive aairways
d. Primary apulmonary ahypertension
ANS: aA
Restriction ais aoften aassociated awith athe afollowing: ainterstitial alung adiseases, aincluding
aidiopathic afibrosis, apneumoconioses, aand asarcoidosis.
DIF: 1 REF: p. a19 a| ap. a21 OBJ: EL-3 MSC: aNBRC: aNone
10. For awhich aof athe afollowing aconditions amight apulmonary afunction atesting abe
acontraindicated?
a. Vocal acord adysfunction
b. Untreated apneumothorax
c. Congestive aheart afailure a(CHF)
d. Bronchiolitis aobliterans
ANS: aB
Pulmonary afunction atests aare ausually acontraindicated ain athe apresence aof
apneumothorax. aHowever, aundiagnosed apneumothorax amay apresent aa arisk aif apulmonary
afunction astudies aare aperformed.
DIF: 1 REF: p. a23 OBJ: EL-4
aMSC: aNBRC: aCPFT a2B-6
d.
11. Which aof athe afollowing acorrectly adescribe(s) aappropriate aphysical ameasurements
|
12th Edition, By Mottram
Chapter 1 - 13 Updated
,Chapter 1: Indications for Pulmonary Function Testing Test Bank
MULTIPLE CHOICE
1. Who first popularized spirometry for the evaluation of pulmonary function?
a. August and Marie Krogh
b. Alvan Barach
c. John Severinghaus
d. John Hutchinson
ANS: D
Hutchinson popularized the concept of using VC to assess lung function, and the names he
gave to several other lung compartments are still used today.
DIF: 1 REF: p. 2 OBJ: None MSC: NBRC: None
2. Which of the following are indications for performing spirometry?
1. Assess the risk of lung resection.
2. Determine the response to bronchodilator therapy.
3. Assess the severity of restrictive lung disease.
4. Quantify the extent of COPD.
a. 1 and 4
b. 2 and 3
c. 1 , 2, and 4
d. 2 , 3, and 4
ANS: C
Spirometry cannot assess severity of restriction; for that you need to measure lung volumes (
see Box 1-2, Chapter 1).
DIF: 1 REF: p. 7 OBJ: EL-2 MSC: NBRC: None
3. The main indication for the measurement of lung volumes is to do which of the following?
a. Diagnose or assess the severity of restriction.
b. Evaluate the severity of pulmonary hypertension.
c. Determine the level of cardiopulmonary fitness.
d. Assess the risk of abdominal surgical procedures.
ANS: A
The most common reason for measuring lung volumes is to identify restrictive lung
disease. DIF: 1 REF: p. 35 OBJ: EL-2 MSC: NBRC: None
4. DLCO measurements may be indicated to evaluate pulmonary involvement in which of
the following systemic diseases?
, a. Asthma
b. Sarcoidosis
c. Exertional hypoxemia
d. Guillain-Barré syndrome
ANS: B
Sarcoidosis is the only systemic disease listed that affects gas exchange.
DIF: 1 REF: p. 9 | p. 19 | p. 21 | p. 35 OBJ: EL-2 MSC: NBRC: None
5. Blood gas analysis is used with patients with COPD to do which of the
following?
a. Monitor airway responsiveness.
b. Determine level of cardiopulmonary fitness.
c. Detect pulmonary hypertension.
d. Assess need for supplementary O2.
ANS: D
Blood gas analysis is most commonly used to determine the need for supplemental oxygen
and to manage patients who require ventilatory support.
DIF: 2 REF: p. 15 OBJ: EL-1
MSC: NBRC: CPFT 2A-2
6. Which of the following cause emphysema?
1. 1- Antitrypsin deficiency
2. Exposure to environmental pollutants
3. Radiation therapy
4. Cigarette smoking
a. 1 and 2
b. 3 and 4
c. 1 , 2, and 4
d. 2 , 3, and 4
ANS: C
Emphysema is caused primarily by cigarette smoking. Some emphysema is caused by the
absence of a protective enzyme. Chronic exposure to environmental pollutants can also
contribute to the development of emphysema.
DIF: 1 REF: p. 11 OBJ: EL-3 | AL-2 MSC: NBRC: None
7. An adult patient complains of chest tightness and cough whenever he jogs in cold
weather. These symptoms are consistent with which of the following?
a. Cystic fibrosis
b. Asthma
c. Pulmonary hypertension
d. Idiopathic pulmonary fibrosis
|
, ANS: aB
Agents aor aevents athat acause aan aasthmatic aepisode aare acalled atriggers a(see aBox a1-7,
aChapter a1). aAntigens asuch aas aanimal adander, apollens, aand adusts aare athe amost
acommon atriggers. aOther acommon atriggers ainclude aexposure ato aair apollutants aand
aexercise ain acold aor adry aair.
DIF: 2 REF: p. a16 OBJ: EL-3 MSC: aNBRC: aNone
8. Which aof athe afollowing astatements aconcerning atumors ain athe aupper aairway ais atrue?
a. There amay abe avariable aor afixed aobstruction.
b. Fixed aobstruction awill abe apresent.
c. Variable aobstruction awill abe apresent.
d. Small aairway aobstruction awill aresult.
ANS: aA
Tumors ainvolving athe aupper aairway amay acause avariable aor afixed aobstruction.
DIF: 2 REF: p. a19 OBJ: EL-2
aMSC: aNBRC: aCPFT a3C-3
9. Sarcoidosis ais aa asystemic adisorder athat ausually acauses awhich aof athe afollowing?
a. A arestrictive aventilatory adefect
b. An aobstructive aventilatory adefect
c. Hyperreactive aairways
d. Primary apulmonary ahypertension
ANS: aA
Restriction ais aoften aassociated awith athe afollowing: ainterstitial alung adiseases, aincluding
aidiopathic afibrosis, apneumoconioses, aand asarcoidosis.
DIF: 1 REF: p. a19 a| ap. a21 OBJ: EL-3 MSC: aNBRC: aNone
10. For awhich aof athe afollowing aconditions amight apulmonary afunction atesting abe
acontraindicated?
a. Vocal acord adysfunction
b. Untreated apneumothorax
c. Congestive aheart afailure a(CHF)
d. Bronchiolitis aobliterans
ANS: aB
Pulmonary afunction atests aare ausually acontraindicated ain athe apresence aof
apneumothorax. aHowever, aundiagnosed apneumothorax amay apresent aa arisk aif apulmonary
afunction astudies aare aperformed.
DIF: 1 REF: p. a23 OBJ: EL-4
aMSC: aNBRC: aCPFT a2B-6
d.
11. Which aof athe afollowing acorrectly adescribe(s) aappropriate aphysical ameasurements
|
